tiprankstipranks

Quest Diagnostics price target raised to $189 from $184 at Baird

Baird analyst Eric Coldwell raised the firm’s price target on Quest Diagnostics (DGX) to $189 from $184 and keeps an Outperform rating on the shares.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue